Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:14 PM
Ignite Modification Date:
2025-12-24 @ 2:14 PM
NCT ID:
NCT07141095
Eligibility Criteria:
Inclusion Criteria:
* Hematopoietic Stem Cell Transplant Recipients
1. Adult patients with an expected survival of ≥4 weeks.
2. Confirmed CMV infection, including CMV viremia and CMV disease.
3. Fully understand the content of the trial, voluntarily participate and complete the trial, and voluntarily sign the informed consent form.
Exclusion Criteria:
* Participants who meet any of the following criteria are not eligible for this study:
1. Patients currently participating in other CMV-related clinical studies, such as those receiving anti-CMV drug treatment or involved in CMV vaccine clinical studies.
2. At screening, liver function tests show: AST \> 5×ULN, or ALT \> 5×ULN, or total bilirubin ≥ 3.0×ULN.
3. Patients with psychiatric disorders or severe psychological conditions that may affect the ability to provide informed consent or participate in follow-up consultations.
4. Participants deemed unsuitable for inclusion by the investigator.
Sex:
ALL
Minimum Age:
12 Years
Study:
NCT07141095
Study Brief:
Protocol Section:
NCT07141095